Gentian Diagnostics ASA

kr 39.10As of Sun 8 Nov 2026, 12:00 UTC
OSL:GENTHealthcare
Country Norway
PE (Fwd) •••
TSR 10Y CAGR (2.83%)
Div yield 1.53%
ROE (2.58%)
Medical Devices
Beta (5Y) 0.52
PE TTM —
TSR TTM (28.21%)
Mkt cap kr 604.4M
ROIC 23.90%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 38
(2.16%)
(97.47%)
Hold 6|12|5|9|4
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.56
0.60
0.60
0.58
28.21%
27.30%
15.27%
2.93%
Revenuekr M
31.58
32.75
33.55
32.98
7.14%
7.45%
10.65%
5.15%
Peers (US$63.94M)
Cap (US$)
PE
592.1M
31.38x
17.53M
—
63.92M
14.56x
Capital
TTM
5Y
10Y
Leveragex
1.266
(0.156)
(0.148)
EBIT/Intx
1.064
0.357
0.357
Own earn%
266.75
(59.81)
(58.75)
Sh yield%
11.71
10.32
11.13
Owners
Insiders/Inst%
12.56
75.66
Short interest%
2.70
SBC / revenue%
5.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
8–15
$1 testx
0.0
Incr. ROIC%
5